Sign in

NCT03756480Active, not recruiting

Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance

Prospective Clinical Study of the Relationship Between Cancer Driving Mutations Found in Endometriotic Implants and the Development of Progesterone Resistance

Source: ClinicalTrials.gov · Last updated 14 Oct 2026

Brief summary (registry, in English)

This study will test the hypothesis that the molecular changes present in ectopic endometriosis lesions correlate with progesterone-resistant disease (using the criteria defined in this study) and are present in matched eutopic endometrium.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
135 (estimated)
First submitted
27 Nov 2018
Start date
1 Oct 2020
Primary completion date
1 Oct 2024
Lead sponsor
Johns Hopkins University
NCT number
NCT03756480

What you commit to

  • Study type: Observational
  • Planned participants: 135
  • From 1 Oct 2020 to the primary completion date, 1 Oct 2024
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of any kind of steroidal therapy including oral contraceptives, Norplant, estrogen replacement/supplemental therapy, androgens (Danazol, Cyclomen, Danocrine, testosterone) or progesterone. She may not be taking or be on Celebrex.
  • Treatment with intrauterine device (IUD) or progestin-containing intrauterine device.

Other illness

  • Presence of pelvic infection.
  • History of cancer of the reproductive tract.
  • Presence of undiagnosed uterine bleeding.

Other

  • Pregnant.
  • Mullerian anomalies with absence of a cervix.

Who the study is looking for

  • Signed informed consent.
  • Gender: female.
  • Age: 18-45 years at the time of signing consent.
  • Clinical or surgical diagnosis of endometriosis undergoing laparoscopy.
  • Controls may not have clinical or surgical diagnosis of endometriosis.
  • Regular menstrual cycles.
  • BMI between 18-40 kg/m2.
  • Sexually active or have had a previous vaginal exam that used a speculum.
  • English speaking

Age in the registry: 18 years to 45 years · Sex: Female

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Johns Hopkins Hospital
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status
Vanderbilt University Medical Center
Coordinator of this site? Confirm its status
NashvilleUnited StatesUnknown status
Yale School of Medicine
Coordinator of this site? Confirm its status
New HavenUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.